Reaction
Non-Alcoholic Steatohepatitis reporting signals
As of the last recalculation, Non-Alcoholic Steatohepatitis appears in 1,036 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is RIFAXIMIN (PRR 35.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rifaximin | 36 | 35.7 | 35.8 |
| Nicotine Polacrilex Mini | 11 | 14.9 | 14.9 |
| Nicotine Polarilex | 11 | 14.9 | 14.9 |
| Diclofenac Potassium, Film Coated | 6 | 14.4 | 14.4 |
| Diclofenac Potassium Tablets | 6 | 14.4 | 14.4 |
| Febuxostat Tablets 40 Mg | 7 | 13.9 | 13.9 |
| Febuxostat Tablets 80 Mg | 7 | 13.9 | 13.9 |
| Diclofenac Potassium | 6 | 11.2 | 11.2 |
| Canakinumab | 6 | 11.2 | 11.2 |
| Buprenorphine Hydrochloride, Naloxone Hydrochloride | 13 | 11.0 | 11.0 |
| Pegaspargase | 5 | 8.2 | 8.2 |